Bolt Biotherapeutics Inc (BOLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2011 | 06-2010 | 06-2009 | 06-2008 | 06-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 5,527 | 4,954 | 10,501 | 14,569 | 10,607 |
| Depreciation Amortization | 1,219 | 707 | 766 | 667 | 319 |
| Income taxes - deferred | -148 | -71 | -100 | 57 | -2 |
| Accounts receivable | -372 | 5,366 | -509 | -453 | -3,009 |
| Accounts payable and accrued liabilities | -482 | -327 | -1,521 | -1,136 | 1,274 |
| Other Working Capital | -2,126 | 6,468 | -1,871 | -5,315 | -6,501 |
| Other Operating Activity | 1,648 | -4,398 | 2,471 | 1,789 | 1,978 |
| Operating Cash Flow | $5,266 | $12,699 | $9,737 | $10,178 | $4,666 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 2,041 | -2,041 | N/A | N/A |
| PPE Investments | -417 | -233 | -386 | -1,683 | -949 |
| Net Acquisitions | -11,184 | -627 | -760 | 606 | N/A |
| Investing Cash Flow | $-11,601 | $1,181 | $-3,187 | $-1,077 | $-949 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 0 | N/A | N/A | 0 | 403 |
| Common Stock Repurchased | -877 | -83 | N/A | -5 | N/A |
| Other Financing Activity | -573 | -25 | 9 | 53 | 1,288 |
| Financing Cash Flow | $-1,450 | $-108 | $9 | $48 | $1,691 |
| Beginning Cash Position | 39,468 | 25,696 | 19,137 | 9,988 | 4,580 |
| End Cash Position | 31,683 | 39,468 | 25,696 | 19,137 | 9,988 |
| Net Cash Flow | $-7,785 | $13,772 | $6,559 | $9,149 | $5,408 |
| Free Cash Flow | |||||
| Operating Cash Flow | 5,266 | 12,699 | 9,737 | 10,178 | 4,666 |
| Capital Expenditure | -417 | -233 | -386 | -1,683 | -949 |
| Free Cash Flow | 4,849 | 12,466 | 9,351 | 8,495 | 3,717 |